Cerus (CERS) Free Cash Flow (2010 - 2026)
Cerus (CERS) reported Free Cash Flow of -$3.3 million for Q1 2026, down 243.31% on a YoY basis from $2.3 million in Q1 2025, and down 167.08% sequentially from $4.9 million in Q4 2025.
Cerus (CERS) Free Cash Flow (2010 - 2026) Analysis & Trends
Cerus (CERS) has 17 years of Free Cash Flow data on file, last reported at -$3.3 million in Q1 2026.
- For the quarter ending Q1 2026, Free Cash Flow fell 243.31% year-over-year to -$3.3 million; the trailing twelve-month figure through Mar 2026 stood at -$1.2 million (down 118.16% YoY), and the FY2025 full-year result was $1.1 million, down 87.0% from the prior year.
- Free Cash Flow retreated to -$3.3 million in Q1 2026, from $4.9 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $4.9 million in Q4 2025 to a low of -$21.6 million in Q1 2022.
- A 5-year average of -$4.1 million and a median of -$2.6 million in 2022 frame the typical range for Free Cash Flow.
- Across the five-year window, Free Cash Flow tumbled 2131.68% in 2023 and jumped 126.05% in 2024, its largest moves.
- Tracing CERS's Free Cash Flow over 5 years: stood at -$3.0 million in 2022, then sank by 407.42% to -$15.2 million in 2023, then jumped by 126.05% to $4.0 million in 2024, then increased by 23.78% to $4.9 million in 2025, then slumped by 167.08% to -$3.3 million in 2026.
- Business Quant data shows CERS's Free Cash Flow at -$3.3 million in Q1 2026, $4.9 million in Q4 2025, and $94000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.45 Bn | 175.15 Bn | 6.27 Bn | 916.00 Mn |
| 2 | Stryker | 128.93 Bn | 126.05 Bn | 3.81 Bn | 415.00 Mn |
| 3 | Medtronic | 108.03 Bn | 98.81 Bn | 6.41 Bn | 2.09 Bn |
| 4 | Boston Scientific | 68.19 Bn | 66.74 Bn | 3.61 Bn | 171.00 Mn |
| 5 | Edwards Lifesciences | 48.22 Bn | 44.55 Bn | 1.29 Bn | -21.10 Mn |
| 6 | Dexcom | 28.24 Bn | 27.13 Bn | 750.30 Mn | 449.00 Mn |
| 7 | GE HealthCare Technologies | 27.99 Bn | 25.70 Bn | 1.98 Bn | 112.00 Mn |
| 8 | Smith & Nephew | 27.01 Bn | 26.43 Bn | - | - |
| 9 | Koninklijke Philips | 23.72 Bn | 20.60 Bn | 2.07 Bn | 305.56 Mn |
| 10 | Cerus | 604.75 Mn | 524.33 Mn | 27.89 Mn | -3.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.28 Mn |
| Mar 31, 2026 | -3.28 Mn |
| Dec 31, 2025 | 4.89 Mn |
| Dec 31, 2025 | 4.89 Mn |
| Sep 30, 2025 | 94,000.00 |
| Sep 30, 2025 | 94,000.00 |
| Jun 30, 2025 | -2.92 Mn |
| Jun 30, 2025 | -2.92 Mn |
| Mar 31, 2025 | -956,000.00 |
| Mar 31, 2025 | -956,000.00 |
| Dec 31, 2024 | 3.95 Mn |
| Dec 31, 2024 | 3.95 Mn |
| Sep 30, 2024 | 3.35 Mn |
| Sep 30, 2024 | 3.35 Mn |
| Jun 30, 2024 | 360,000.00 |
| Jun 30, 2024 | 360,000.00 |
| Mar 31, 2024 | 860,000.00 |
| Mar 31, 2024 | 860,000.00 |
| Dec 31, 2023 | -15.18 Mn |
| Dec 31, 2023 | -15.18 Mn |